Skip to content
MedsAcross

Medicine

Gadoteridol 5586 mg/20 mL injection

Gadoteridol · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Gadoteridol 5586 mg/20 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

DO NOT FREEZE. Should freezing occur in the vial, Gadoteridol Injection, USP…

Key facts

Active ingredient (INN)
Gadoteridol
Brand
Sold under the generic name
Strength
5586 mg/20 mL
Dosage form
Injection
Route
Intravenous
Packs
5 vials of 20 mL
Manufacturer
Slate Run Pharmaceuticals
Origin register
US FDA, United States
Storage
DO NOT FREEZE. Should freezing occur in the vial, Gadoteridol Injection, USP should be brought to room temperature before use. Store at 20° to 25°C (68° to77° F). Excursions permitted to 15°C to 30°C (59°F to 86°F). If allowed to stand at room temperature for a minimum of 60 minutes, Gadoteridol Injection, USP should return to a clear, colorless to slightly yellow solution. Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
V08CA04 Gadoteridol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
20 February 2025
Identifiers
DailyMed set ID 538a70e0-061c-40d2-8447-5b7a4e61a55fNDC 70436-121Application ANDA218749

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
5 vial, single-dose in 1 carton / 20 mL in 1 vial, single-dose70436-121-35Slate Run Pharmaceuticals20 February 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 16 November 1992Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Gadoteridol 5586 mg/20 mL injection.

Compare 1

Other strengths and forms of Gadoteridol

Clinical summary

Gadoteridol is a paramagnetic contrast agent indicated for magnetic resonance imaging (MRI) to visualize, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Gadoteridol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Gadoteridol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Gadoteridol 5586 mg/20 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.